FinTrust Capital Advisors LLC Acquires 128 Shares of The Procter & Gamble Company (NYSE:PG)

FinTrust Capital Advisors LLC boosted its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 1.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,219 shares of the company’s stock after acquiring an additional 128 shares during the quarter. FinTrust Capital Advisors LLC’s holdings in Procter & Gamble were worth $1,852,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Capital Investment Advisory Services LLC lifted its holdings in shares of Procter & Gamble by 4.9% during the 4th quarter. Capital Investment Advisory Services LLC now owns 36,681 shares of the company’s stock valued at $5,559,000 after buying an additional 1,711 shares during the period. Deuterium Capital Management LLC bought a new position in shares of Procter & Gamble during the 4th quarter valued at $675,000. Sweet Financial Partners LLC lifted its holdings in shares of Procter & Gamble by 25.3% during the 1st quarter. Sweet Financial Partners LLC now owns 10,422 shares of the company’s stock valued at $1,550,000 after buying an additional 2,106 shares during the period. CX Institutional increased its stake in shares of Procter & Gamble by 4.1% in the 4th quarter. CX Institutional now owns 33,743 shares of the company’s stock worth $5,114,000 after purchasing an additional 1,320 shares in the last quarter. Finally, Oak Harbor Wealth Partners LLC increased its stake in shares of Procter & Gamble by 11.1% in the 4th quarter. Oak Harbor Wealth Partners LLC now owns 30,891 shares of the company’s stock worth $4,682,000 after purchasing an additional 3,089 shares in the last quarter. 64.65% of the stock is owned by institutional investors.

Procter & Gamble Trading Up 1.6 %

Shares of Procter & Gamble stock opened at $151.74 on Friday. The firm has a market cap of $357.65 billion, a price-to-earnings ratio of 26.44, a PEG ratio of 4.15 and a beta of 0.41. The business has a 50-day moving average price of $150.41 and a 200-day moving average price of $147.39. The company has a quick ratio of 0.39, a current ratio of 0.59 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a twelve month low of $122.18 and a twelve month high of $158.11.

Procter & Gamble (NYSE:PGFree Report) last issued its quarterly earnings data on Friday, April 21st. The company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.32 by $0.05. Procter & Gamble had a return on equity of 32.18% and a net margin of 17.69%. The firm had revenue of $20.07 billion during the quarter, compared to analyst estimates of $19.32 billion. During the same quarter last year, the business posted $1.33 earnings per share. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. Equities research analysts anticipate that The Procter & Gamble Company will post 5.86 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, May 15th. Investors of record on Friday, April 21st were issued a $0.9407 dividend. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.91. The ex-dividend date was Thursday, April 20th. This represents a $3.76 dividend on an annualized basis and a dividend yield of 2.48%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.51%.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Raymond James upped their price objective on Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research note on Sunday, April 23rd. JPMorgan Chase & Co. upgraded Procter & Gamble from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $150.00 to $155.00 in a research note on Friday, March 3rd. Morgan Stanley increased their price target on Procter & Gamble from $160.00 to $174.00 and gave the stock an “overweight” rating in a research note on Monday, April 24th. Evercore ISI increased their price target on Procter & Gamble from $160.00 to $170.00 and gave the stock an “outperform” rating in a research note on Monday, April 24th. Finally, StockNews.com assumed coverage on Procter & Gamble in a research note on Thursday, May 18th. They issued a “buy” rating for the company. Five research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $161.50.

Insider Activity at Procter & Gamble

In related news, CFO Andre Schulten sold 25,244 shares of the stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $155.27, for a total value of $3,919,635.88. Following the completion of the transaction, the chief financial officer now owns 27,118 shares of the company’s stock, valued at approximately $4,210,611.86. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,000 shares of the firm’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $156.03, for a total value of $4,836,930.00. Following the completion of the sale, the chief operating officer now owns 10,014 shares of the company’s stock, valued at $1,562,484.42. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 25,244 shares of the firm’s stock in a transaction dated Monday, April 24th. The stock was sold at an average price of $155.27, for a total transaction of $3,919,635.88. Following the completion of the sale, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at approximately $4,210,611.86. The disclosure for this sale can be found here. In the last quarter, insiders sold 95,093 shares of company stock valued at $14,821,930. Insiders own 0.26% of the company’s stock.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.